Ivor Royston, CEO & President at Viracta Therapeutics, Inc. (VIRX), bought 8,000 shares at $5.56 ($44K) on 2021-11-15, disclosed to the SEC on 2021-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VIRX | SELL | 2022-03-01 | $41K | — | Filing → |
| BIOC | BUY | 2017-03-29 | $50K | — | Filing → |
| SNDX | BUY | 2016-03-08 | $1.8M | — | Filing → |